NCT07078955 - A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

March 31, 2027

Conditions

Dry Eye Disease (DED)Keratoconjunctivitis Sicca

Interventions

DRUG

BRM421 Ophthalmic Solution, 0.03%

A topical drop of 0.03% BRM421 ophthalmic solution.

DRUG

Artificial Tear

A topical drop of Artificial Tear.

DRUG

BRM421 Ophthalmic Solution, 0.06%

A topical drop of 0.06% BRM421 ophthalmic solution.

Trial Locations (1)

New Taipei Municipal TuCheng Hospital, New Taipei City